BRIEF-Flamel Technologies reaches agreement with FDA on protocol for phase III pivotal trial of FT218
Oct 6 Flamel Technologies SA :
* Flamel Technologies reaches agreement with fda on protocol for phase III pivotal trial of FT218
* Phase III trial commenced patient enrollment in canada, with sites in Europe and U.S. to be initiated near-term
* Says agreement was reached through special protocol assessment process Source text for Eikon: Further company coverage:
One dead in ENI Congo oil platform fire
BRAZZAVILLE, Dec 3 One person was killed in a fire on an oil platform operated by ENI Congo off the coast of the Congo Republic city of Pointe-Noire, the government said.
Aixtron, Fujian to explore what is left of deal after U.S. veto
FRANKFURT, Dec 3 German semiconductor equipment maker Aixtron will explore with its Chinese suitor what can be salvaged of the planned takeover after a U.S. presidential order ruled the deal posed a national security risk, the company said on Saturday.